ASSESSING THE EFFICACY OF TREATMENTS FOR PANIC DISORDER AND AGORAPHOBIA .2. THE PANIC AND AGORAPHOBIA SCALE
ASSESSING THE EFFICACY OF TREATMENTS FOR PANIC DISORDER AND AGORAPHOBIA .2. THE PANIC AND AGORAPHOBIA SCALE
复制标题
DOI：
10.1097/00004850-199506000-00003
复制
发表时间：
1995-06-01
影响因子：
2.6
通讯作者：
BANDELOW, B
中科院分区：
文献类型：
--
作者：
BANDELOW, B
尽管焦虑症和广场恐怖症的评定量表过多，一个合格的量表评估恐慌症和广场恐怖症（PDA）的严重程度仍然缺乏。本文介绍了一种新的惊恐与广场恐怖量表（P & A）。它是根据DSM-III-R/IV或ICD-10的标准诊断后开发的，用于评估这些疾病的严重程度。P & A是专门为临床药物试验而开发的。影响惊恐障碍和广场恐怖症患者生活质量的因素（惊恐发作、恐惧回避、预期焦虑、社会关系和工作障碍、躯体疾病的假设）在该量表的开发中被考虑，以便可以单独评估某些药物治疗对每个因素的疗效。观察者评分和带有匹配项的自我评分都可用。观察者评级仅需约10分钟即可完成。计划将其翻译成多种欧洲语言，以便在多中心试验中使用。在项目分析、评分员间信度、客观性、外部效度和因素结构等方面取得了满意的结果。P & A应该是评估PDA严重程度的有用工具，并可能解决以前PDA研究中出现的一些方法学问题。
Despite the plethora of rating scales for anxiety disorders and agoraphobia, a qualified scale for assessing the severity of panic disorder and agoraphobia (PDA) is still lacking. The new Panic and Agoraphobia Scale (P & A) is presented in this paper. It was developed to assess the degree of severity of these disorders after a diagnosis has been made according to the criteria of the DSM-III-R/IV or the ICD-10. The P & A was specially developed for use in clinical drug trials. Factors which impair the quality of life in panic disorder and agoraphobia patients (panic attacks, phobic avoidance, anticipatory anxiety, impairment in social relationships and work, assumption of somatic disease) were considered in the development of this scale so that the efficacy of a certain drug therapy on each of these factors can be assessed separately. Both an observer rating and a self-rating with matching items are available. The observer rating only takes about 10 minutes to complete. Translation into many European languages is planned so that it can be used in multicentre trials. Satisfactory results of item analysis, inter-rater reliability, objectivity, external validity and factor structure are presented. The P & A should be a useful tool for assessing the severity of PDA and may solve some of the methodological problems that have arisen in former PDA studies.